Literature DB >> 9824161

A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110.

S B Cohen1, R Nicol, E Stavnezer.   

Abstract

sno is a member of the ski oncogene family and shares ski's ability to transform avian fibroblasts and induce muscle differentiation. Ski and Sno are nuclear proteins that form homodimers and heterodimers. Ski activates transcription of cellular and viral enhancers and we have identified a DNA binding site (GTCTAGAC) through which it represses transcription. In this work, we show that SnoN binds this site and represses transcription of reporters with this binding site as an upstream element. Using fusions with the Gal4-DNA binding domain in a heterologous reporter assay, we identify a tripartite repression domain in SnoN. A 107 amino acid stretch of the SnoN repression domain, that contains two of the subdomains, is closely related to the minimal region of Ski required for transformation. The third subdomain is unique to SnoN. By analysing deletions involving each of the subdomains, we show that subdomains II and III are also required for DNA binding and cellular transformation. We provide evidence for a quenching mechanism of transcriptional repression by which subdomain II binds to TAF(II)110.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824161     DOI: 10.1038/sj.onc.1202177

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases.

Authors:  Yuexing Zhang; Nicholas Woodford; Xianmin Xia; Anne W Hamburger
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

2.  An efficient strategy to identify early TPA-responsive genes during differentiation of HL-60 cells.

Authors:  Ling-Yueh Hu; Clifford G Tepper; Su-Hao Lo; Wen-Chang Lin
Journal:  Gene Expr       Date:  2006

3.  Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor.

Authors:  T Nomura; M M Khan; S C Kaul; H D Dong; R Wadhwa; C Colmenares; I Kohno; S Ishii
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

4.  Dual role of SnoN in mammalian tumorigenesis.

Authors:  Qingwei Zhu; Ariel R Krakowski; Elizabeth E Dunham; Long Wang; Abhik Bandyopadhyay; Rebecca Berdeaux; G Steven Martin; LuZhe Sun; Kunxin Luo
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

5.  Defective T-cell activation is associated with augmented transforming growth factor Beta sensitivity in mice with mutations in the Sno gene.

Authors:  S Pearson-White; M McDuffie
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

6.  Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.

Authors:  Dong Dong Luo; Aled Phillips; Donald Fraser
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

7.  SKI controls MDS-associated chronic TGF-β signaling, aberrant splicing, and stem cell fitness.

Authors:  David E Muench; Kyle Ferchen; Chinavenmeni S Velu; Kith Pradhan; Kashish Chetal; Xiaoting Chen; Matthew T Weirauch; Clemencia Colmenares; Amit Verma; Nathan Salomonis; H Leighton Grimes
Journal:  Blood       Date:  2018-09-24       Impact factor: 22.113

8.  SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers.

Authors:  June A Chia; Lisa A Simms; Sarah-Jane Cozzi; Joanne Young; Jeremy R Jass; Michael D Walsh; Kevin J Spring; Barbara A Leggett; Vicki L J Whitehall
Journal:  BMC Cancer       Date:  2006-10-24       Impact factor: 4.430

9.  Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease.

Authors:  Angeles C Tecalco-Cruz; Diana G Ríos-López; Genaro Vázquez-Victorio; Reyna E Rosales-Alvarez; Marina Macías-Silva
Journal:  Signal Transduct Target Ther       Date:  2018-06-08

10.  Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.

Authors:  Laurence Levy; Michael Howell; Debipriya Das; Sean Harkin; Vasso Episkopou; Caroline S Hill
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.